Press Releases
Valo Health to Participate in Upcoming Conferences and Events
Valo & Charles River's Logica News: Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs
Valo Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
Valo Health - FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart Failure
Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference
Valo's David Berry to Deliver Keynote at Founders Network's fnSummit 2022
KSM Research and Innovation Center and Valo Health Announce First-of-Its-Kind Multiyear Collaboration to Spearhead Preventative Care and Personalized Medicine for Patients
Valo Health to Participate in UBS Biotechnology Virtual Private Company Symposium
Valo Health To Participate in Citi's 17th Annual BioPharma Conference
Valo Announces First Patient Dosed in the OPL-0401 Phase 2 study of an oral ROCK1/2 inhibitor for the Treatment of Non-Proliferative Diabetic Retinopathy
Valo Health to Participate in June Conferences and Events
Valo Health Announces Publication of the Journal of Clinical Investigation of a New Therapeutic Approach to Improve CD8+ T Cell Function
Valo Health to Present at UBS Global Healthcare Conference 2022
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform
Valo Health to Present at Oppenheimer 32nd Annual Healthcare Conference
Valo Health CEO David Berry to Participate in 2022 BIO CEO & Investor Conference
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
Valo Health Names Dave Morris Chief Medical Officer
Valo Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
David Berry to Participate in NewYorkBio and New York Stock Exchange Emerging Biotech Company Showcase
Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement
Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments
Previous
Next
gg